Rare Patient Voice has been acquired by Konovo
January 2026 — Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Rare Patient Voice empowers patients and family caregivers to have their voices heard through participation in research, including market research, health economics, outcomes research, real-world evidence studies, user experience, human factors research and clinical trials. Its community includes over 200,000 patients and caregivers spanning more than 1,500 diseases, both rare and non-rare, across nine countries. By fostering trusted relationships and delivering high-quality insights, Rare Patient Voice enables research that reflects real-world patient experiences.
Konovo is a global healthcare company on a mission to transform research through technology and connected insights. It simplifies the research process, connects fragmented insights and enhances access to healthcare audiences including physicians, patients, caregivers and allied healthcare professionals through its intelligent platform and expert-guided solutions. Operating across the Americas, Europe and Asia, Konovo supports market research agencies, consultancies and life science and healthcare brands with deep, actionable insights.
Our role in the transaction
Oaklins DeSilva+Phillips, based in New York, served as the exclusive financial advisor to Rare Patient Voice in this transaction, highlighting its deep sector expertise in advising healthcare technology businesses, particularly within the insights and analytics industry.
Contáctese con el equipo de la transacción
Elaine Riddell
Oaklins DeSilva+Phillips
Ken Sonenclar
Oaklins DeSilva+Phillips
Transacciones relacionadas
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Conozca másKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Conozca másNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Conozca más